{"number":"US12697324B2","kindCode":"B2","documentType":"grant","title":{"original":"Use of compound as CYP2E1 inhibitor","english":"Use of compound as CYP2E1 inhibitor"},"abstract":{"original":"A use of a compound as a CYP2E1 inhibitor includes: using a compound shown in formula (I) or a salt thereof as an inhibitor to inhibit CYP2E1, where the compound or the salt thereof targets and binds to CYP2E1. The inhibitor can be used for the prevention and treatment of a tumor including liver cancer, glioma, ovarian cancer, lung cancer, bladder cancer, and gallbladder cancer.…","english":"A use of a compound as a CYP2E1 inhibitor includes: using a compound shown in formula (I) or a salt thereof as an inhibitor to inhibit CYP2E1, where the compound or the salt thereof targets and binds to CYP2E1. The inhibitor can be used for the prevention and treatment of a tumor including liver cancer, glioma, ovarian cancer, lung cancer, bladder cancer, and gallbladder cancer.…"},"applicants":["Suzhou Lingxi Biotechnology Co., Ltd."],"inventors":["Hailing QIAO","Haiwei XU","Yan FANG","Na GAO","Qiang WEN","Shufeng LI"],"filingDate":"2023-03-01","publicationDate":"2026-08-04","grantDate":"2026-08-04","verifiedWithOffice":true,"pdfUrl":"https://downloadpatent.com/pdf/US12697324B2.pdf","pages":{"en":"https://downloadpatent.com/patent/US12697324B2","zh-Hant":"https://downloadpatent.com/zh-Hant/patent/US12697324B2","ja":"https://downloadpatent.com/ja/patent/US12697324B2"}}